These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Losartan: the first angiotensin receptor antagonist in clinical use. Beevers DG J Hum Hypertens; 1995 Nov; 9 Suppl 5():S1. PubMed ID: 8583475 [No Abstract] [Full Text] [Related]
3. Angiotensin II receptor inhibition. A new therapeutic principle. Messerli FH; Weber MA; Brunner HR Arch Intern Med; 1996 Sep; 156(17):1957-65. PubMed ID: 8823149 [TBL] [Abstract][Full Text] [Related]
4. [The medicine of the month. Losartan (Cozaar)]. Scheen AJ Rev Med Liege; 1997 May; 52(5):367-9. PubMed ID: 9273640 [No Abstract] [Full Text] [Related]
5. [Angiotensin-II receptor blockers]. Metelitsa VI Ter Arkh; 1996; 68(8):64-7. PubMed ID: 9019837 [No Abstract] [Full Text] [Related]
6. Angiotensin II receptor antagonism: losartan - sites and mechanisms of action. Triggle DJ Clin Ther; 1995; 17(6):1005-30. PubMed ID: 8750395 [TBL] [Abstract][Full Text] [Related]
7. Angiotensin II receptors and angiotensin II receptor antagonists. Timmermans PB; Wong PC; Chiu AT; Herblin WF; Benfield P; Carini DJ; Lee RJ; Wexler RR; Saye JA; Smith RD Pharmacol Rev; 1993 Jun; 45(2):205-51. PubMed ID: 8372104 [No Abstract] [Full Text] [Related]
8. The future role of losartan. Hansson L J Hum Hypertens; 1995 Nov; 9 Suppl 5():S55-8. PubMed ID: 8583483 [TBL] [Abstract][Full Text] [Related]
9. New angiotensin-II blocker. Lilley LL; Guanci R Am J Nurs; 1996 Mar; 96(3):20. PubMed ID: 8607540 [No Abstract] [Full Text] [Related]
11. [Angiotensin receptor antagonists. A new class of antihypertensive agents]. Mann J Dtsch Med Wochenschr; 1996 Apr; 121(17):568-71. PubMed ID: 8620827 [No Abstract] [Full Text] [Related]
12. Angiotensin II receptor blockers. A new class of antihypertensive drugs. Velasquez MT Arch Fam Med; 1996 Jun; 5(6):351-6. PubMed ID: 8640326 [TBL] [Abstract][Full Text] [Related]
13. [Renin-angiotensin system blockade. What can be expected from angiotensin II antagonists?]. Waeber B; Nussberger J; Brunner H Rev Prat; 1992 Oct; 42(16):2066-8. PubMed ID: 1485114 [No Abstract] [Full Text] [Related]
15. [Antihypertensive advantages of angiotensin II AT1 receptor antagonism]. Coca A; Giner V Rev Esp Cardiol; 1999; 52 Suppl 3():53-8. PubMed ID: 10614150 [TBL] [Abstract][Full Text] [Related]
16. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review. Dahlöf B J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480 [TBL] [Abstract][Full Text] [Related]
17. Angiotensin II receptor antagonists: the prototype losartan. Schaefer KL; Porter JA Ann Pharmacother; 1996 Jun; 30(6):625-36. PubMed ID: 8792950 [TBL] [Abstract][Full Text] [Related]
18. Anti-hypertensive therapy by losartan. How effective is AT1 receptor blockade? Brunner HR J Hum Hypertens; 1995 Nov; 9(11):859-60. PubMed ID: 8583462 [No Abstract] [Full Text] [Related]
19. The angiotensin II receptor antagonist losartan: a new advance in the treatment of hypertension. Lacourcière Y Can J Cardiol; 1995 Aug; 11 Suppl F():45F-48F. PubMed ID: 7664218 [TBL] [Abstract][Full Text] [Related]
20. The diversified pharmacology of angiotensin II-receptor blockade. Timmermans PB; Smith RD Blood Press Suppl; 1996; 2():53-61. PubMed ID: 8913541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]